Advertisement
Screener

HARVARD BIOSCIENCE, INC. (HBIO) Other General Expense

2.8 / 5 stars · 68/120 Roast Me

HARVARD BIOSCIENCE, INC. Other General Expense

HARVARD BIOSCIENCE, INC. (HBIO) reported Other General Expense of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OtherGeneralExpense · last filed 2016-04-29

  • HARVARD BIOSCIENCE, INC. other general expense for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. other general expense for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. other general expense for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. other general expense for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. other general expense for fiscal 2015 was $0.00.
  • HARVARD BIOSCIENCE, INC. other general expense for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
  • HARVARD BIOSCIENCE, INC. other general expense for fiscal 2013 was $2.05M, a 194.25% increase from fiscal 2012.
  • HARVARD BIOSCIENCE, INC. other general expense for fiscal 2012 was $696.00K, a 332.30% increase from fiscal 2011.
Period endOther General Expense 3 monthOther General Expense 6 monthOther General Expense 9 monthOther General Expense 12 month
2015-12-31$0.00
10-K · filed 2016-04-29
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
$0.00
derived: sum of 2 quarters · filed 2016-04-29
$0.00
derived: sum of 3 quarters · filed 2016-04-29
$0.00
10-K · filed 2016-04-29
2014-09-30$0.00
10-Q · filed 2014-11-06
$0.00
derived: sum of 2 quarters · filed 2014-11-06
$0.00
10-Q · filed 2014-11-06
$260.00K
derived: sum of 4 quarters · filed 2016-04-29
2014-06-30$0.00
10-Q · filed 2014-08-07
$0.00
10-Q · filed 2014-08-07
$260.00K
derived: sum of 3 quarters · filed 2016-04-29
$528.00K
derived: sum of 4 quarters · filed 2016-04-29
2014-03-31$0.00
10-Q · filed 2014-05-08
$260.00K
derived: sum of 2 quarters · filed 2016-04-29
$528.00K
derived: sum of 3 quarters · filed 2016-04-29
$1.54M
derived: sum of 4 quarters · filed 2016-04-29
2013-12-31$260.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
$528.00K
derived: sum of 2 quarters · filed 2016-04-29
$1.54M
derived: sum of 3 quarters · filed 2016-04-29
$2.05M
10-K · filed 2016-04-29
2013-09-30$268.00K
10-Q · filed 2014-11-06
$1.28M
derived: sum of 2 quarters · filed 2014-11-06
$1.79M
10-Q · filed 2014-11-06
2013-06-30$1.02M
10-Q · filed 2014-08-07
$1.52M
10-Q · filed 2014-08-07
2013-03-31$503.00K
10-Q · filed 2014-05-08
2012-12-31$696.00K
10-K · filed 2015-03-12
2011-12-31$161.00K
10-K · filed 2014-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Precipio, Inc. (PRPO)United States$0.043B-36.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15